Exemed operates two manufacturing facilities which are located in Guajarat, India. It also operates in API and intermediate manufacturing facilities, each of which complies with the regulatory requirements in the jurisdictions in which it operates. Between them, these facilities have received approvals from various prominent international regulatory bodies, including from U.S. Food and Drug Administration (FDA).
Each of Exemed’s manufacturing facilities is designed, equipped and operated to deliver high quality products within defined cost and delivery schedules. These manufacturing facilities have flexibility to operate in various dosage forms and wide range of batch sizes.
API Manufacturing Facility
In 2009, Exemed commissioned a latest state-of-art API-Manufacturing unit, in Baroda to manufacture Metformin API having Capacity of 5000 MTs per annum with a focus on global-quality-norms & technology.
API facility is approved by various regulatory bodies like USFDA, EU GMP, KFDA Etc.
The facility also has multiproduct block to manufacture 250 MTs API annually.
628 A & B, ECP Canal Road,
At. & Po. Luna, Taluka : Padra
District : Vadodara Gujarat, INDIA
Finished Formulation Manufacturing Facillity
In June 2013, Exemed completed acquisition of UCB India’s manufacturing unit in Vapi, which is equipped to manufacture solid oral, Liquid dosage, API & Intermediates forms.
The facility has annual capacity to manufacture 2400 Million tablets & 240 Million capsules which can be scaled further & approved by regulatory bodies like EUGMP, WHO GMP & GUJARAT FDA.
The facility is vertically integrated to manufacture 36 MTs of API & 100 MTs of Intermediates annually.
Plot No. 133/1 & 133/2,GIDC,
Selvas Road,Vapi-396 195, Taluka : Pardi
District : Valsad, Gujarat, INDIA